Pharmacovigilance is Everyone's Concern: Let's Work It Out Together

Abstract

In recent decades, the field of drug safety/pharmacovigilance (PV) has advanced dramatically in some ways and yet has remained stagnant or progressed slowly in others. One way to assess the PV landscape is to view it through both a regulatory lens and a science and technology lens. This commentary highlights some of the current PV issues that can be resolved by sustained collaboration among all relevant stakeholders.

Keywords: adverse events; drug safety; pharmacovigilance; regulatory.